WASHINGTON DC USA -- PHARMA UPDATE NEWS SERVICE -- MAY 26, 2020: National Pharma Webinars, www.PharmaAudioConferences.com/, will present a webinar on Global Roundtable on Special Issues Raised by the COVID-19 Pandemic for Medical Device Ethics and Compliance Professionals and In-House Counsel on June 4, 2020 at 10:00 am (Eastern). The webinar is sponsored by Policy & Medicine Compliance Update, Harvard Health Policy Review, and Health Affairs. Registration discounts are offered to employees of a member company of the Pharmaceutical Compliance Forum (PCF), www.PharmaComplianceForum.org, or the International Society of Healthcare Ethics and Compliance Professionals (ETHICS), www.ethicspros.com.
WEBINAR FACULTY
|
Arwa Asiri, MHA
Compliance Officer, Mecomed, Compliance Officer, Conference Vetting System, Dubai, UAE |
Campbell Clark, LLB, MJ
Chief Ethics and Compliance Officer, Asia Pacific, Medtronic, Covidien Private Limited, Chair, Legal, Ethics and Compliance Committee, Asia Pacific Medical Technology Association (APACMed), Singapore |
Peter Jensen, JD
Global Chief Compliance Officer, Arthrex, Naples, FL
|
Nancy Travis, MA
Vice President, Global Compliance and Governance, AdvaMed, Washington, DC |
Roeland Van Aelst
EMEA Lead Third Party Intermediary Ethics and Compliance, Johnson & Johnson, Chairman, International Society of Healthcare, Ethics and Compliance Professionals (ETHICS), Chairman, MedTech Europe Code Committee, Brussels, Belgium |
Justin Will, JD
Sr. Principal, Global Commercial Compliance Consulting & Managed Services, IQVIA; Former Sr. Compliance Officer, North America & EMEA, Arthrex; Former Regional Compliance Officer, Americas, bioMerieux; Naples, FL (Moderator)
|
|
|
WHAT IS A WEBINAR?
|
It is a live event available on-line as a Zoom video presentation that includes an interactive question and answer period. Individual access can be purchased, or group access for up to 3 or more participants at one site using one log-in. During the live Webinar participants will be able to ask questions and make comments. The Webinar faculty has agreed to take follow-up questions via email.
Pharma and Medical Device Ethics & Compliance Webinars are simple, accessible, cost effective and reach a broad audience locally.
|
|
|